Hospital
Randolph Hospital INC.
Randolph Hospital INC. was paid $5.83M by Medicaid between Jan 2018 and Sep 2021, across 78 billing codes. Its largest line is 99284, emergency room visit (serious) — 24% of everything it billed.
33Billing provider infoRANDOLPH HOSPITAL INC.
ASHEBORO, NC 27203
ASHEBORO, NC 27203
33aNPI1255328449assigned 10/03/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.83M
24GClaims165,987
24DCodes billed78
24AFirst – last monthJan 2018 – Sep 2021
Compared with peers
Next to other General Acute Care Hospital providers in North Carolina
Rank by total paid#61 of 92
Median peer was paid$11.47M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 52,680 | $1.80M | |
| 2019 | 49,600 | $1.74M | |
| 2020 | 35,394 | $806K | |
| 2021 | 28,313 | $1.48M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 24% | 11,191 | 10,503 | $1.42M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 24% | 9,450 | 8,783 | $1.40M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 10,561 | 10,000 | $972K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.8% | 4,041 | 3,792 | $162K |
| 71046 | Radiologic examination, chest; 2 views | 2.6% | 3,445 | 3,325 | $151K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.3% | 365 | 342 | $135K |
| 80053 | Comprehensive metabolic panel | 2.2% | 15,967 | 13,822 | $130K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.8% | 959 | 888 | $102K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.7% | 5,978 | 5,288 | $98K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 14,819 | 12,925 | $98K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.6% | 1,649 | 1,362 | $93K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.6% | 2,047 | 799 | $92K |
66 more codes
| 71045 | Radiologic examination, chest; single view | 1.5% | 3,205 | $85K |
| 41899 | Unlisted procedure, dentoalveolar structures | 1.4% | 73 | $84K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.4% | 336 | $80K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.2% | 1,271 | $68K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.1% | 1,287 | $62K |
| G0378 | Hospital observation service, per hour | <1% | 490 | $49K |
| 83880 | <1% | 2,405 | $46K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,235 | $45K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 3,314 | $43K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,471 | $36K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,818 | $35K |
| 81001 | <1% | 11,283 | $34K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 16,395 | $32K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 163 | $27K |
| 81025 | <1% | 3,695 | $26K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 407 | $24K |
| 84484 | <1% | 5,330 | $24K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 576 | $18K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 449 | $16K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 25 | $16K |
| J3490 | Unclassified drugs | <1% | 2,895 | $15K |
| 85730 | <1% | 3,384 | $11K | |
| Q3014 | Telehealth originating site facility fee | <1% | 234 | $10K |
| 11045 | <1% | 42 | $8K | |
| 83690 | <1% | 1,466 | $8K | |
| 86592 | <1% | 426 | $8K | |
| 85610 | <1% | 3,473 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 393 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 740 | $5K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 12 | $5K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 59 | $5K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 102 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 58 | $4K |
| A9270 | Non-covered item or service | <1% | 5,299 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 294 | $4K |
| 87807 | <1% | 312 | $3K | |
| 85027 | <1% | 529 | $2K | |
| 81002 | <1% | 895 | $2K | |
| 80320 | <1% | 23 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,177 | $2K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 58 | $2K |
| 36591 | <1% | 65 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 25 | $917.02 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 160 | $691.11 |
| 73610 | <1% | 12 | $635.58 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 18 | $531.16 |
| 85007 | <1% | 172 | $478.97 | |
| 83605 | <1% | 80 | $474.17 | |
| 87040 | <1% | 134 | $427.58 | |
| 84145 | <1% | 24 | $363.86 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 143 | $361.07 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13 | $283.26 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $283.26 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 140 | $220.29 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 121 | $219.14 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 49 | $197.90 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 105 | $187.08 |
| 82728 | <1% | 13 | $113.98 | |
| 86140 | <1% | 24 | $101.55 | |
| 87210 | <1% | 25 | $95.00 | |
| 85379 | <1% | 13 | $80.36 | |
| 83550 | <1% | 13 | $73.47 | |
| 83540 | <1% | 13 | $56.42 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 12 | $44.72 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 17 | $16.86 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWHITE, LYNWOOD (CFO)
| Provider | Location | Paid |
|---|---|---|
| Randolph Hospital INC | Asheboro, NC | $336.46 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.